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Abstract- Because of the overwhelming scattering of light in 
biological tissues, the spatial resolution and imaging depth of 
conventional fluorescent imaging is unsatisfactory. Therefore, 
we present a dual modality imaging technique by combining 
fluorescence imaging with high-resolution noninvasive 
photoacoustic tomography (PAT) for the study of an animal 
tumor model. PAT provides high-resolution structural images 
of tumor angiogenesis, and fluorescence imaging offers high 
sensitivity to molecular probes for tumor detection. 
Coregistration of the PAT and fluorescence images was 
performed on nude mice with M21 human melanoma cell lines 
with ?v?3 integrin expression. An integrin ?v?3–targeted 
peptide–ICG conjugated NIR fluorescent contrast agent was 
used as the molecular probe for tumor detection. PAT was 
employed to noninvasively image the brain structure and the 
angiogenesis associated with tumors in mice. The 
coregistration between the PAT and fluorescence images was 
used to visualize tumor location, angiogenesis, and brain 
structure simultaneously.  
I.   INTRODUCTION
Photoacoustic tomography (PAT) is an emerging imaging 
modality that takes advantage of both high optical contrast 
and good ultrasound resolution [1]. It is a nonionizing 
imaging modality based upon the different absorption rates 
at which different biological tissues absorb electromagnetic 
waves. In PAT, an electromagnetic wave in the visible or 
Near–infrared (NIR) region irradiates a biological sample to 
generate photoacoustic waves according to the thermoelastic 
mechanism. The acoustic waves can be detected by highly 
sensitive piezoelectric devices. With the detected 
photoacoustic signals, the distribution of electromagnetic 
absorption in the sample can be reconstructed. PAT has 
been shown to be a promising tool for biomedical 
applications, such as the monitoring of oxygenation in blood 
vessels, epidermal melanin measurement, angiography, and 
breast tumor detection [2]. 
Fluorescence results from a three–stage (excitation, 
excited–state Lifetime, and fluorescence emission) process 
that occurs when certain molecules (generally polyaromatic 
hydrocarbons or heterocycles), called fluorophores, or 
fluorescent dyes, absorb light. The absorption of light by a 
population of these molecules raises their energy level to a 
brief excited electronic singlet state. As they decay 
(typically within 1–10 nanoseconds) from this excited state, 
they emit fluorescent light. Fluorescence imaging is highly 
sensitive, and it can be used to image a variety of molecular 
properties due to its versatile fluorescent probe design [3][4]. 
Recently, Li and Ke et al. developed an integrin ?v?3–
targeted peptide, conjugated with ICG as a fluorescent 
molecular imaging contrast agent, for the noninvasive in
vivo visualization of M21 human melanoma tumors with 
?v?3 integrin expression where the integrin ?v?3 plays an 
important role in the tumor angiogenesis and metastasis 
[5][6].  Fluorescence imaging shows strong potential for the 
diagnostic imaging of tumors. 
The development of noninvasive diagnostic imaging 
techniques is an area of great clinical interest. Such imaging 
tools are critical for the study of tumor detection and tumor 
physiology, such as angiogenesis. PAT and near-infrared 
(NIR) fluorescence imaging are noninvasive techniques that 
can both provide complementary structural information 
about angiogenesis as well as detect tumors. Here, we 
present the results from the coregistration of PAT and 
molecular fluorescence imaging obtained with a mouse 
tumor model. In vivo experiments were performed to render 
this dual modality imaging method. The experimental setup 
is described below. 
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Fig. 1. (A) Experimental setup of in vivo photoacoustic tomography of a 
small animal head.
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Fig. 1. (B)  Experimental setup of in vivo fluorescence imaging of a 
small animal head with a peptide–ICG contrast agent. 
II.   MATERIALS AND METHODS 
A.   Photoacoustic Tomography  
The setup for non–invasive in vivo PAT of the nude 
mouse head is shown in Fig. 1(A).  A tunable Ti:Sapphire 
nanosecond pulse laser (LT–2211A, Lotis T II, Minsk, 
Belarus) pumped by an Nd:YAG laser (LS–2137/2, Lotis T 
II, Minsk, Belarus), was employed to provide laser pulses 
with a repetition rate of 10 Hz and a wavelength of 785 nm. 
The incident energy density of the laser beam on the surface 
of the mouse head was reduced by a concave lens and 
ground glass until it was less than 2 mJ/cm2, which is much 
less than the maximum value allowed by the ANSI standard. 
An unfocused ultrasonic transducer (XMS–310, 
Panametrics), with an active element of 2 mm in diameter, a 
center frequency of 10.4 MHz, and a -6dB fractional 
bandwidth of 100%, was used to detect the photoacoustic 
signals. A computer–controlled step motor drove the 
transducer to circularly scan the cortical surface of the 
mouse brain with a radius of 3.5 cm and a step size of 1.5o.
The data acquisition time for one image was ~15 minutes. 
An electronic shutter system was employed to reduce the 
duration of the mouse head exposure to the pulse laser light. 
Since the mouse head was exposed to the laser light only 
during the data acquisition rather than during the whole 
scanning circle, the decay of the peptide–ICG conjugated 
contrast agent was reduced. In order to couple the 
photoacoustic signals, the transducer was immersed in a 
water tank. The mouse was fixed by a homemade mount 
with its head protruding into the water tank through a hole 
in the bottom of the tank. The hole was sealed with a piece 
of polyethylene membrane. The mouse head surface was 
covered with a thin layer of ultrasonic coupling gel. The 
detected photoacoustic signals were amplified and then 
digitized by an oscilloscope. The digitized signals were 
transferred to a computer, and the distribution of the optical 
absorption in the imaging plane (x-y plane) was 
reconstructed using a modified back-projection algorithm 
after a full view scanning [7].  
The PAT was realized by a circular scan from a single 
element transducer.  Images obtained by this system 
represent a distribution of averaged optical absorption 
during the period of data acquisition. In the future, when an 
ultrasonic transducer array is employed, we will utilize real–
time monitoring and achieve more accurate PAT images. 
B.   Near-infrared Fluorescence Imaging 
Fig. 1(B) shows the non–invasive in vivo fluorescence 
imaging setup for nude mice with a peptide-ICG contrast 
agent. The mouse head was illuminated with light from a 
laser diode (785 nm, 80mW), expanded to a ~5 cm diameter 
circular area. A macro lens, coupled with a cooled CCD 
camera (BU401–BR, Andor Technology, CT), collected the 
emitted fluorescent light from the conjugated ICG 
molecules. The lens was fitted with a notch–plus filter and a 
bandpass filter. Images were acquired and stored using the 
application that came with the CCD camera. Matlab (The 
MathWorks, Inc., Natick, MA) and Photoshop (Adobe 
Systems, Inc., San Jose, CA) were used to process and 
analyze the images.
C.   Animal Protocols  
Nude mice weighing about 20 grams were used in the in
vivo animal experiments. A dose of 87 mg/kg Ketamine, 
plus Xylasine 13 mg/kg administered intramuscularly, was 
used to anesthetize the mice during the experiments. M21 
human melanoma tumor cells were inoculated 
subcutaneously on the heads of the nude mice. When the 
tumors grew to a size of about 5 mm diameter, the peptide–
ICG conjugated contrast agent was injected into the 
circulatory system of the mice via tail vein injection, leading 
to an estimated concentration of 10 µM in mouse blood. The 
fluorescence imaging and PAT were conducted 24 hours 
after the ICG injection.  
III.   RESULTS
Fig. 2(A) shows the NIR fluorescent image of a nude 
mouse inoculated with an M21 human melanoma tumor and 
injected with an integrin ?v?3–targeted peptide–ICG 
conjugated contrast agent. The signal intensity of the tumor 
region was significantly higher than that of background due 
to the uptake of the contrast agent by the ?v?3 integrin 
receptor. This fluorescence image shows the location and 
shape of the tumor. 
In the PAT image (Fig. 2 (B)), the nude mouse brain 
structure and vascular system were clearly displayed with a 
higher resolution. In the experiments, the mice were fixed 
on the same mount, and the fluorescent images were 
acquired form the top of the mice heads in a perpendicular 
direction (Fig. 1 (B)). Since the acquired PAT nude mouse 
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brain images also included the perpendicular direction, 
coregistration between the PAT images and fluorescent 
images became feasible.  
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Fig. 2. (A) Noninvasive in vivo fluorescence image acquired 24 hours 
after the ICG injection, overlapped on a white-light image. (B) 
Noninvasive in vivo PAT image acquired 24 hours after the ICG 
injection with skin and skull intact. (C) Coregistered noninvasive in vivo
image of PAT and fluorescence imaging. (D) Open skin and skull 
photograph. 
The coregistered image of the PAT and fluorescence 
imaging is shown in Fig. 2(C). The fluorescence image was 
overlapped on top of the PAT image. Comparing Fig. 2(B) 
with the open skull photograph, Fig. 2(D), we find that the 
brain structure is well matched except for the dashed circled 
vessel in Fig. 2 (B), which is not shown on the surface of 
the brain. Based on the coregistered image, the vessel 
marked in Fig. 2 (B) is one of the major feeding vessels of 
the tumor. 
IV.   CONCLUSION
A dual modality imaging method combining PAT and 
molecular fluorescence imaging is successfully employed to 
both image the angiogenesis of the brain containing a tumor 
and to detect the tumor. A tumor-targeted NIR fluorescent 
contrast agent is used for the tumor detection. By combining 
PAT and fluorescence imaging, the tumor location, the 
tumor angiogenesis, and the brain structure of the nude 
mouse can all be visualized at the same time.  
This method offers important possibilities for combining 
different imaging modalities. In the future, we will study 
PAT molecular imaging using multiple optical wavelengths. 
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